A study by Brscic E et al. involving young Italian patients with AMI concluded that the AGTR1 A1166C polymorphism was not related to the composite end points of major cardiovascular events, including cardiovascular mortality, myocardial infarction, and revascularization procedures during the follow-up period of 46 ± 12 months [13]. The gene discussed is AGTR1; the disease is myocardial infarction.